Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Alloo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The British Journal of Dermatology|March 5, 2015
Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicitiesA Alloo, J Sheu, J E Butrynski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2018
Ixazomib-induced cutaneous necrotizing vasculitisA Alloo, H Khosravi, S R Granter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2014
Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetilA Alloo, L Strazzula, B Rothschild, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The British Journal of Dermatology|March 5, 2015
Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicitiesA Alloo, J Sheu, J E Butrynski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2018
Ixazomib-induced cutaneous necrotizing vasculitisA Alloo, H Khosravi, S R Granter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2014
Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetilA Alloo, L Strazzula, B Rothschild, et al.
Pageof 1